These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 27416147)

  • 1. In Vitro Activity of Tigemonam Against Multiresistant Nosocomial Enterobacteriaceae.
    Giamarellou H; Pephanis A; Grammatikou M; Avlamis A; Papoulias G
    J Chemother; 1989 May; 1(sup2):32-35. PubMed ID: 27416147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of tigemonam against multiresistant nosocomial Enterobacteriaceae.
    Giamarellou H; Pephanis A; Grammatikou M; Avlamis A; Papoulias G
    J Chemother; 1989 May; 1 Suppl 2():32-5. PubMed ID: 2809700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Activity of Tigemonam Against Urinary Tract Pathogens.
    Garcia-Rodriguez JA; Garcia-Sanchez JE
    J Chemother; 1989 May; 1(sup2):28-31. PubMed ID: 27416146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial Activity of Tigemonam Dicholate (SQ 30836) and Interaction With Beta-Lactamases of Gram-Negative Bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1(sup2):13-21. PubMed ID: 27416144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of tigemonam against urinary tract pathogens.
    Garcia-Rodriguez JA; Garcia-Sanchez JE
    J Chemother; 1989 May; 1 Suppl 2():28-31. PubMed ID: 2809699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity of tigemonam dicholate (SQ 30836) and interaction with beta-lactamases of gram-negative bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1 Suppl 2():13-21. PubMed ID: 2809698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial Activity In Vitro of Tigemonam, a New Oral Monobactam.
    Schito GC; Debbia E; Bandelloni R; Paglia P; Pesce A
    J Chemother; 1989 May; 1(sup2):41-44. PubMed ID: 27416149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity in vitro of tigemonam, a new oral monobactam.
    Schito GC; Debbia E; Bandelloni R; Paglia P; Pesce A
    J Chemother; 1989 May; 1 Suppl 2():41-4. PubMed ID: 2809702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigemonam, an oral monobactam.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 Jan; 32(1):84-91. PubMed ID: 3279906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies of tigemonam: a comparison of the minimum inhibitory and minimum bactericidal concentrations (MIC vs MBC).
    Gobernado M; Cantón E
    J Chemother; 1989 May; 1 Suppl 2():36-40. PubMed ID: 2809701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in-vitro activity of tigemonam, a new monobactam.
    Rylander M; Gezelius L; Norrby SR
    J Antimicrob Chemother; 1988 Sep; 22(3):307-13. PubMed ID: 3182428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Studies of Tigemonam: a Comparison of the Minimum Inhibitory and Minimum Bactericidal Concentrations (MIC vs MBC).
    Gobernado M; Cantón E
    J Chemother; 1989 May; 1(sup2):36-40. PubMed ID: 27416148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal Activity of Tigemonam, Alone and in Combination with Gentamicin.
    Shah PM; Gànger-Farshid G; Mulert R; Stille W
    J Chemother; 1989 May; 1(sup2):45-46. PubMed ID: 27416150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal activity of tigemonam, alone and in combination with gentamicin.
    Shah PM; Gänger-Farshid G; Mulert R; Stille W
    J Chemother; 1989 May; 1 Suppl 2():45-8. PubMed ID: 2809703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of tigemonam, a novel oral monobactam.
    Tanaka SK; Summerill RA; Minassian BF; Bush K; Visnic DA; Bonner DP; Sykes RB
    Antimicrob Agents Chemother; 1987 Feb; 31(2):219-25. PubMed ID: 3105448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of tigemonam, a novel oral monobactam.
    Clark JM; Olsen SJ; Weinberg DS; Dalvi M; Whitney RR; Bonner DP; Sykes RB
    Antimicrob Agents Chemother; 1987 Feb; 31(2):226-9. PubMed ID: 3551830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth Curve Patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris Submitted to Different Tigemonam Concentrations.
    Yourassowsky E; Linden MP; Lismont MJ; Crokaert F
    J Chemother; 1989 May; 1(sup2):49-53. PubMed ID: 27416151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.